Payment of financial incentives to GPs may invalidate informed consent process - PubMed (original) (raw)
Payment of financial incentives to GPs may invalidate informed consent process
C Ferguson. BMJ. 1998.
No abstract available
Similar articles
- Ethical and financial considerations in third-party support of investigational cancer therapies.
Young FE. Young FE. Cancer. 1993 Nov 1;72(9 Suppl):2854-8. doi: 10.1002/1097-0142(19931101)72:9+<2854::aid-cncr2820721517>3.0.co;2-2. Cancer. 1993. PMID: 8402519 - Conflict of interest and informed consent in industry-sponsored clinical trials.
Shimm DS, Spece RG Jr. Shimm DS, et al. J Leg Med. 1991 Dec;12(4):477-513. doi: 10.1080/01947649109510865. J Leg Med. 1991. PMID: 1800586 Review. No abstract available. - Informed consent: how informed and consent to what?
Lilleyman JS. Lilleyman JS. Pediatr Hematol Oncol. 1995 Nov-Dec;12(6):xiii-xvi. doi: 10.3109/08880019509030764. Pediatr Hematol Oncol. 1995. PMID: 8588995 No abstract available. - [Pharmaceutical industry and clinical drug research].
Huttunen MO. Huttunen MO. Duodecim. 2000;116(24):2813-5. Duodecim. 2000. PMID: 12077886 Review. Finnish. No abstract available.
Cited by
- Clinical trials in primary care: targeted payments for trials might help improve recruitment and quality.
Foy R, Parry J, McAvoy B. Foy R, et al. BMJ. 1998 Oct 31;317(7167):1168-9. doi: 10.1136/bmj.317.7167.1168. BMJ. 1998. PMID: 9794845 Free PMC article. No abstract available. - Recruitment and retention in a multicentre randomised controlled trial in Bell's palsy: a case study.
McKinstry B, Hammersley V, Daly F, Sullivan F. McKinstry B, et al. BMC Med Res Methodol. 2007 Mar 28;7:15. doi: 10.1186/1471-2288-7-15. BMC Med Res Methodol. 2007. PMID: 17391510 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical